Clinical Trials Logo
  1. Home
  2. Intestinal Diseases
  3. NCT01929044

Efficacy of Buscopan® in Comparison With 654-II (Anisodamine) in Acute Gastric or Intestinal Pain

Intestinal Diseases Clinical Trial

Official title:
A Randomized, Double-blind, Independent 3rd Party Unblind, Active-controlled, Parallel-group, Multi-center Trial, in Contrast With Anisodamine (654-II), 10mg, to Evaluate the Efficacy and Safety of Buscopan® Solution for Injection, 20mg (Intramuscularly) for the Treatment of Acute Gastric or Intestinal Spasm-like Pain

Clinical Trial Summary

The aim of the study is to assess the efficacy of Buscopan® (hyoscine butylbromide) in comparison to 654-II (anisodamine)in acute gastric or intestinal spasm-like pain.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01929044
Study type Interventional
Source Boehringer Ingelheim
Contact
Status Completed
Phase Phase 3
Start date August 2013
Completion date February 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT03032861 - The Prebiotic Effect of Daily Intake of Orange Juice Affects the Bioavailability of Flavanones? N/A
Recruiting NCT02295254 - Microbiome Changes in Travelers to Tropical Destinations N/A
Completed NCT02246647 - Biomarkers for Intestinal Permeability in Patients With Constipation
Recruiting NCT05322486 - Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Active, not recruiting NCT01037049 - Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks Phase 2
Completed NCT01872286 - Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2 N/A
Completed NCT04080843 - Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients Phase 2
Terminated NCT04644315 - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors Phase 2
Completed NCT02445365 - Remote Ischemic Conditioning in Patients With Ulcerative Colitis N/A
Recruiting NCT04949282 - Spanish Series of Patients Treated With the Radionuclide Lutetium177
Active, not recruiting NCT01995942 - Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial
Completed NCT02647866 - Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis Phase 2
Completed NCT02693782 - Fabulous Fibre Study - Effect of Wheat Bran Extract on Gut and General Health in Healthy Aging Subjects (FFS) N/A
Not yet recruiting NCT02806206 - Prucalopride Prior to Small Bowel Capsule Endoscopy Phase 4
Completed NCT02831556 - Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Terminated NCT04102163 - Health-Related Quality of Life in Crohn's Disease Participants With Complex Perianal Fistula Before and After Treatment
Terminated NCT02550860 - Influence of Fish Oil Based Intravenous Fat Emulsions on the Epidermal Barrier Function Phase 3
Recruiting NCT02044952 - Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission Phase 2/Phase 3
Completed NCT02227602 - Anti-Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease N/A
Active, not recruiting NCT01028898 - Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome N/A